Respiratory syncytial virus (RSV) remains the top cause of hospitalization among young children, leading to respiratory ...

AUSTIN (KXAN) — In 2023, the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) ...

Fall is here and so is respiratory virus season. The main three that will circulate between October and May are COVID-19, ...

GSK announced on Tuesday that a single dose of its Arexvy vaccine against respiratory syncytial virus (RSV) was 43.3% ...

U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...

Adults who are at risk of severe RSV are 75 years or older. Also, people between 60 and 74 years old who have chronic health ...

Respiratory Illness season is right around the corner and experts are urging parents to take action to protect their newborns ...

GSK said on Tuesday that its Arexvy respiratory syncytial virus vaccine was 43.3% effective in preventing severe illness in ...

In another blow to its $525 million buyout of ReViral, Pfizer has ended development of sisunatovir, an oral inhibitor ...

Clinician-scientists analyzed samples from patients' airways and blood, finding distinct changes in children with severe cases of RSV, including an increase in the number of natural killer (NK) cells ...

As the days grow cooler, families across Utah are reminded that respiratory viruses, particularly Respiratory Syncytial Virus ...

There’s about 270 different viruses that can infect humans, and in the fall and winter we're inside more where they can ...